1. Introduction {#sec1}
===============

Diabetes Mellitus (DM) is known as one of the largest global threats of the 21^st^ century in developed countries as well as in developing countries. Type 2 diabetes mellitus (T2DM) is characterized by constant hyperglycaemia due to the condition called insulin resistance in targeted organs and pancreatic β cell dysfunction, leading to deterioration in insulin secretions ([@bib7]). A survey from the International Diabetes Federation (IDF) in 2017 stated that globally 425 million people are suffering from DM in which more than 90 % of them have T2DM and, 629 million people may get diabetes by 2045 ([@bib10]). Factors such as genetic susceptibility, environmental factors, obesity, physical inactivity, high sugar, fat-rich diets, etc. are believed to be responsible for the pathogenesis of T2DM. For the treatment of T2DM, several oral medications as well as injectable drugs have been available for decades, targeting a different kind of organ systems. Nevertheless, the main strategies of T2DM drugs are directed towards the control of hyperglycaemia and maintenance of the normal blood glucose homeostasis in the body ([@bib25]).

Amongst the many drug targets of T2DM, starch digesting enzymes such as alpha amylase and intestinal alpha glucosidase are targeted to achieve inhibition of these enzymes and hence to control the postprandial hyperglycaemia. Alpha glucosidases \[EC 3.2.1.20\] are digestive enzymes that belong to a family called 'glycosides', located in the brush border surface membrane of small intestinal cells that take part in the last step of carbohydrate digestion. These enzymes exclusively catalyse the hydrolysis of α-1,2, α-1,4 and α -1,6-glucosidic linkages in oligosaccharides and thereby release absorbable monosaccharides ([@bib49]). Currently, acarbose, miglitol and voglibose are used as alpha glucosidase inhibitors (AGI) which are isolated from microbes. Unfortunately, severe adverse effects like vomiting, liver disorders, flatulence, abdominal discomfort, hypoglycaemia, urinary tract infection, etc. have been noticed in patients medicated with acarbose, miglitol and voglibose. Even though, the acarbose is a common drug prescribing as an AGI to treat T2DM ([@bib12]; [@bib34]; [@bib56]).

Chronic hyperglycaemia is a condition observed in all forms of DM. According to the earlier reports, hyperglycaemia activates several biochemical pathways in the cells that are prone to the accumulation of reactive oxygen species (ROS). Because of dearth in the proper endogenous antioxidant defence mechanism, excessively accumulated ROS activates the stress-sensitive intracellular signalling pathways, which in turn, promote the cellular damage and play a role in the development of diabetic complications ([@bib14]; [@bib57]). Among the several compounds that have been identified as AGI, generally phenolic compounds from a natural source are identified as the main phytochemicals with antioxidant properties. They work by reducing the accumulation of ROS in diabetic complications ([@bib2]; [@bib8]; [@bib46]). Also, flavonoids, phenylpropanoids, terpenes and quinines are known as good inhibitors of the alpha glucosidase enzyme as listed in a review ([@bib62]). Even though myriad of phytochemical compounds have been reported from plant sources, there are no reports on the commercialization of phytochemicals as AGI so far. This lacuna was the drive for investigations to find a more potent natural AGI molecule from *Simarouba glauca* plant.

*Simarouba glauca* DC is rain-fed wasteland tree commonly called as 'Laxmitaru' or 'Paradise tree' belonging to the family Simaroubaceae. Different parts of the plant are being used traditionally as, antifungal, antibacterial, antioxidant ([@bib37]; [@bib45]; [@bib55]), antiparasitic, antipyretic and anticancer agents ([@bib24]; [@bib30]). The bark extract of this tree is commonly used for dysentery hence the bark is also called 'dysentery-bark' ([@bib45]; [@bib30]). The seed powder is being used to treat snakebites ([@bib30]). Along with other species of Simaroubaceae family, *S. glauca* also contains a unique group of active compounds called quassinoids (ailanthinone, glaucarubinone, and holacanthone) which are shown to be responsible for the wide spectrum of biological activities of this plant ([@bib3]). Hence, owing to the numerous biological activities reported in earlier studies and lack of comprehensive studies on phytochemical analysis, antioxidant and AGI activities from *S. glauca*, this plant was selected to explore the correlation between phytochemicals and different biological activities.

In this study, crude and purified 'fraction-14' from the ethanol extract of *S. glauca* leaves were analysed for phytochemicals and antioxidant assay followed by yeast alpha glucosidase enzyme inhibition assay. Further, the active 'fraction-14' was characterized by HPLC-Q--TOF-MS analysis and four compounds were tentatively identified for the first time in *S. glauca* leaf extract. The efficacy of alpha glucosidase enzyme inhibition was also studied by enzyme kinetics for purified 'fraction-14'. The binding affinities of the identified compounds were analysed by *in-silico* docking of these compounds to alpha glucosidase enzyme. This study is expected to provide new insight into the potentiality of natural alpha glucosidase enzyme inhibitors as a alternative for the existing AGI to inhibit human alpha glucosidase.

2. Materials and methods {#sec2}
========================

2.1. Chemicals and reagents {#sec2.1}
---------------------------

Alpha glucosidase from *Saccharomyces cerevisiae* (19.3 U/mg, Type1 lyophilized powder, G5003), p-Nitrophenyl-α-D-glucopyranoside (≥99%, N1377), 2, 2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS, ≥98%, A1888), quercetin (≥95% HPLC, Q4951), gallic acid (≥98% ACS reagent, 398225) and acarbose (PHR 1253) were procured from Sigma- Aldrich, India. 2, 2-diphenyl-1-picrylhydrazil (DPPH, 95%, Alfa Aesar-A Johnson Matthey Company) and acetonitrile HPLC grade (4400SP, Qualigens) obtained from Thermo Fisher Scientific India Pvt. Ltd. Vitamin C Purified (≥99%, QH1Q610760) and Methanol HPLC grade (SF8SF68931, 99.7%) were purchased from Merck Specialities Private Ltd, India. Chloroform analytical grade (2H2802300, 99.8%) purchased from SD Fine Chem. Ltd. India (SDFCL). Silica gel (Mesh size: 60--120) purchased from ACME Synthetic Chemicals, India.

2.2. Extraction and purification of active compounds {#sec2.2}
----------------------------------------------------

Fresh leaves were collected from *S. glauca* plants grown on the campus of Poornaprajna Institute of Scientific Research, Devanahalli, Bangalore Rural-562110, India (13.2884° N, 77.6713° E). Leaves were washed immediately in distilled water and air-dried at room temperature (RT), 28 ± 2 °C. Then, fine powder was prepared from the dried leaves using a mixer grinder and stored in polythene bags at 4 °C. The extract from the same powder was used for all the subsequent experiments.

Twenty grams of leaf powder was taken in a conical flask containing 150 mL of ethanol and the soluble content was extracted twice, using a rotary shaker at RT for 12 h. The extract in ethanol was filtered using a muslin cloth and the filtrate was centrifuged at 12,096 x g for 30 min (Eppendorf, 5810 R). The supernatant was collected and dried under vacuum using a rotary evaporator at 40 °C (IKA, RV 10 D S96). The dried extract was weighed and stored at -20 °C for further use.

The dried ethanol extract was re dissolved in absolute ethanol and was loaded on to a glass column (size of 50 × 4.5 cm) packed with the silica gel (60--120 mesh size). The column was equilibrated and eluted using a mobile phase containing chloroform, acetonitrile, and methanol at 5:4:1 ratio at a flow rate of 1 mL/min and collected 12 fractions of 10 mL each. Followed by, the same sample in the column was eluted with 50% aqueous methanol at the same flow rate and 4 fractions of 10 mL each were collected. All the 16 fractions were concentrated into 2 mL each using a rotary evaporator at 40 °C and further dried in a hot air oven at 40 °C and used for analysis.

2.3. Phytochemical assays {#sec2.3}
-------------------------

### 2.3.1. Estimation of total flavonoid {#sec2.3.1}

The total flavonoid content of ethanol extract and purified 'fraction-14' was determined using aluminum chloride assay ([@bib33]) with slight modifications. Ethanol extract and purified 'fraction-14' were dissolved in Milli-Q water at 1 mg/ml concentration respectively, centrifuged at 16,873 x g for 10 min and filtered through 0.2 μm syringe filters before the analysis. The reaction mixture containing 150 μL of NaNO~2~ (0.72 M) and 100 μL of the sample in a 10 mL test tube. Then, the volume was made up to 2650 μL with Milli-Q water and incubated at RT (28 °C) for 5 min. Then 150 μL of AlCl~3~ (0.74 M) was added and incubated at RT for 1 min. Immediately after incubation, 1000 μL of NaOH (1 M) was added and the mixture was diluted to 5000 μL with Milli-Q water. The reaction mixture was mixed thoroughly and centrifuged at 16,873 x g for 5 min and absorbance was read at 510 nm using BioSpectrometer® kinetic (Eppendorf). Similarly, a standard curve was plotted for quercetin (Q) at different concentrations (200--1000 μg/mL) and used as flavonoid standard. The total flavonoid content in the sample extract was represented in milligram (mg) of quercetin equivalent/gram of the extract (mg Q/g extract).

### 2.3.2. Estimation of total phenolics {#sec2.3.2}

The total phenolic content of the ethanol extract and purified 'fraction-14' was determined using the Folin-Ciocalteu (F--C) method ([@bib33]) with slight modifications. Leaf crude extract and purified 'fraction-14' were dissolved in Milli-Q water at 1 mg/ml concentration respectively, centrifuged at 16,873 x g for 10 min and filtered through 0.2 μm syringe filters before the analysis. Briefly, 200 μL of each sample was taken in a test tube and diluted to 500 μL using Milli-Q water. Then 150 μL of F--C reagent was added, stirred and kept for incubation for 6 min at room temperature. Then 1250 μL of Na~2~CO~3~ (1 M) was mixed thoroughly with the reaction mixture and kept for incubation in dark for 2 h. Thereafter, the reaction mixture was made up to 3 mL by diluting with 1100 μL of Milli-Q water and absorbance was measured at 760 nm using Thermoscientific Multiscan® plate reader. A standard curve was plotted using gallic acid (GA) with a concentration range of 200--1600 μg/mL. The total phenolic content was represented as mg gallic acid equivalent per gram of the extract (mg GA/g extract).

2.4. Antioxidant assays {#sec2.4}
-----------------------

### 2.4.1. DPPH assay {#sec2.4.1}

Ethanol crude extract and purified 'fraction-14' were dissolved in methanol at 1 mg/ml concentration, centrifuged at 16,873 x g for 10 min and filtered through 0.2 μm filter before the analysis. The DPPH free radical scavenging activity of the extract was determined using the previously described method with slight modifications ([@bib61]). The reaction mixture in a 96 well plate contained 50 μl of samples at different concentrations (1, 0.5, 0.1 μg/mL; diluted in Milli-Q water) and 100 μL DPPH free radicals (0.2 mM). The final volume was made up to 200 μL with methanol and incubated at RT (28 °C) in dark for 30 min. The control was prepared by replacing the sample with the methanol. Also, sample blanks were prepared for each sample by replacing DPPH free radicals with the methanol. The absorbance was measured at 517 nm using the Thermoscientific Multiscan® plate reader. Ascorbic acid was used as a positive control at different concentration range (1.76, 3.52, 5.28, 7.04 and 8.80 μg/mL) and the standard curve was plotted. DPPH radical scavenging ability of the samples and ascorbic acid was calculated using the [formula (1)](#fd1){ref-type="disp-formula"}.

The absorbance values of control and sample represented are the net values obtained after subtracting the reaction blank and sample blank respectively. The DPPH free radical scavenging activity of the samples were represented in IC~50~ values and compared with ascorbic acid (standard antioxidant).

### 2.4.2. ABTS assay {#sec2.4.2}

Ethanol crude extract and purified 'fraction-14' were dissolved in 100% methanol at 1 mg/ml concentrations, centrifuged at 16,873 x g for 10 min and filtered through 0.2 μm filter before the analysis and ABTS free radical scavenging activity was determined using the protocol previously described with slight modifications ([@bib61]). The ABTS free radical was generated by incubating an equal amount of 7 mM ABTS and 2.4 mM potassium persulphate for 16 h in dark. The absorbance of the free radical was adjusted to optical density of 0.7 ± 0.03 at 734 nm by diluting in methanol. In a 96 well plate, 50 μL of the sample at different concentrations (10, 5, 1, 0.1 and 0.05 μg/mL in Milli-Q water) was taken and 100 μL of ABTS free radicals was added. The final volume was made up to 200 μL with methanol. The reaction mixture was incubated at RT (28 °C) in dark condition for 6 min. The control was prepared by replacing the sample with the methanol. Also, the sample blank was prepared for each sample by replacing ABTS free radicals with the methanol. The absorbance was measured at 734 nm using the Thermoscientific Multiscan® plate reader. Ascorbic acid was used as a positive control and the standard curve was plotted for different concentrations (0.88, 1.76, 2.64, 3.52 and 4.40 μg/mL). ABTS radical scavenging ability of the sample and ascorbic acid was calculated using the [formula (2)](#fd2){ref-type="disp-formula"}.

The absorbance values of control and sample represented are the net values obtained after subtracting the reaction blank and sample blank respectively. The ABTS free radical scavenging activity of the samples were represented in IC~50~ values and compared with ascorbic acid (standard antioxidant).

2.5. Yeast alpha glucosidase inhibition (AGI) assay {#sec2.5}
---------------------------------------------------

Ethanol extract and purified 'fraction-14' were dissolved in Milli-Q water at 10 mg/ml concentration, centrifuged at 16,873 x g for 10 min (Eppendorf, 5418) and filtered through 0.2 μm filters before the analysis. AGI assay was carried out using the previously described method with slight modifications ([@bib6]). Briefly, in a 96 well microplate, the 50 μL of sample at different concentrations (10, 5, 1, 0.1, 0.01, 0.05 and 0.005 μg/mL) mixed with 40 μL (0.0015 units/mL) of yeast alpha glucosidase enzyme and 10 μL of phosphate buffer (100 mM) pH 7. The reaction mixture was incubated at 37 °C for 20 min. Then, 50 μL of the substrate (20 mM p-nitrophenyl-α-D-glucopyranoside (PNPG) was added to the reaction mixture and incubated at 37 °C for 30 min. Immediately, 100 μL of sodium carbonate (200 mM) solution was added to the reaction mixture to retard the enzyme activity. The blank for the reaction was prepared by replacing the sample and enzyme with buffer. Similarly, the control was prepared using a buffer in place of the sample. Also, blank solutions were prepared for each sample by replacing an enzyme with a buffer. The absorbance of p-nitrophenol released during the reaction was quantified by reading at 405 nm using the Thermoscientific Multiscan® plate reader (Multiscan Go 1510). Similarly, the anti-diabetic drug acarbose was used as a standard (10 mg/mL) for the assay. The percentage of alpha glucosidase enzyme inhibition was calculated using the [formula (3)](#fd3){ref-type="disp-formula"}.

The absorbance values of control and sample represented are the net values obtained after subtracting the reaction blank and sample blank respectively. The alpha glucosidase enzyme inhibition activity of the samples was represented in IC~50~ values and compared with acarbose.

2.6. Characterization {#sec2.6}
---------------------

### 2.6.1. UV-visible spectroscopy {#sec2.6.1}

The column purified 'fraction-14' was dissolved in Milli-Q water at 0.25 mg/mL concentration and UV-Visible spectra were measured. The absorbance spectrum was measured from 200-830 nm range using BioSpectrometer® kinetic.

### 2.6.2. Fourier transform infrared spectroscopy (FTIR) {#sec2.6.2}

The column purified 'fraction-14' was analysed using FTIR equipped with a DLATGS detector (BRUKER ALPHA). The dried sample was mixed with KBr at a ratio of 1:100 respectively and the mixture was ground into a fine powder using a mortar and pestle. The thin pellet was prepared and placed on the sample holder of the instrument and scanned at 4000 - 400 cm^−1^ range.

### 2.6.3. HPLC-Q--TOF-MS analysis {#sec2.6.3}

Column purified 'fraction-14' was further characterized using an HPLC equipped with Phenomenex C18 column (Aqua 5 μm, 200Å, 250 × 4.6 mm i.d.) to separate the analytes. Binary mobile phase system consisting solvent A: water +0.1% formic acid and solvent B: acetonitrile 90% + 0.1% formic acid with a gradient elution; 0--15 min (A:95% & B:5%), 15--17 min (A:65% & B:35%), 17--24 min (A:25% & B:75%), 24--30 min (A:95% & B 5%) was used for the elution. The separated analytes were detected from m/z 100--1000 using Accurate Mass Q-TOF- LC/MS (Agilent Technologies, 6520) equipped with dual electrospray ionization source (ESI). Analytes were identified in negative ionization mode using the following instrument conditions; gas flow, 8 L/min; gas temperature, 250 °C; nebulizer 35 psig; capillary voltage, 2750 V. The structures of identified molecules were drawn using the software ChemDraw Pro 8.0.

2.7. Enzyme inhibitory kinetics {#sec2.7}
-------------------------------

Alpha glucosidase enzyme inhibition kinetic study was performed for column purified 'fraction-14' using a modified method previously explained elsewhere ([@bib50]). P-nitrophenyl α-D-glucopyranoside (PNPG) was used as a substrate at different concentration range (0.01--0.8 mM). The enzyme concentration was maintained at 0.02 Units/mL for the experiment. The enzyme kinetic activity was studied in the absence as well as in the presence of inhibitors at different concentrations (0.83--4.15 μg/mL). The mode of enzyme inhibition, *V*~*max*~, and *K*~*m*~ was determined using the following Lineweaver- Burk plot [formula (4)](#fd4){ref-type="disp-formula"}. The inhibitory constant *K*~*i*~ was determined from the graph slope versus inhibitor concentrations.$$\frac{1}{Vo} = {\lbrack\frac{Km}{Vmax}\rbrack} \times \frac{1}{\lbrack S\rbrack} + \frac{1}{Vmax}$$where *V*~*o*~: Initial velocity; *K*~*m*~: Michaelis-Menten constant; *V*~*max*~: Maximum velocity; S: Substrate concentration.

2.8. Molecular docking {#sec2.8}
----------------------

### 2.8.1. Homology model {#sec2.8.1}

The *in-vitro* studies are performed against the alpha glucosidase enzyme from *Saccharomyces cerevisiae.* The protein sequence of alpha glucosidase (MAL12-Yeast) in the FASTA format was retrieved from UniProt (access code P53341). Since the crystal structure of alpha glucosidase from *Saccharomyces cerevisiae* is not available, the 3D structure of the enzyme was generated using RaptorX homology modelling software (<http://raptorx.uchicago.edu/>). The quality of the homology model was authenticated by the Ramachandran plot using PROCHECK software (<https://servicesn.mbi.ucla.edu/PROCHECK/>)*.*

### 2.8.2. Docking study {#sec2.8.2}

A docking study was performed against the homology model of *Saccharomyces cerevisiae* alpha glucosidase enzyme. The protein structure was prepared using the protein preparation module on Maestro with the default setting. The 2D structures of acarbose, kaempferol-3-O-pentoside and kaempferol-3-O-glucoside were retrieved from the PubChem database. Eclalbasaponin V and cyanidin-3-O- (2′galloyl)-galactoside were drawn using PubChem sketcher V2.4 software (<https://pubchem.ncbi.nlm.nih.gov/edit2/index.html>). The 3D conformations of compounds were generated by LigPrep (Schrodinger, LLC, New York, NY, 2015) with default settings using OPLS2005 force field. A docking grid of 20 Å was created around the enzyme active-site and the grid was identified as x: 11.33, y: -0.02 and z: 26.77. Docking was performed using Glide (Schrodinger, LLC, New York, NY, 2015) on Maestro version 10.1. The best docking poses for all the compounds were visually analysed using Pymol software (<https://pymol.org/edu/?q=educational/>).

2.9. Statistical analysis {#sec2.9}
-------------------------

The experiments were done in triplicates (n = 3) and verified as mean ± SD. The inhibition percentage and IC50 values were calculated by performing a regression analysis. Analysis of variance (ANOVA) was implemented and the differences between the values are considered to be statistically significant at p \< 0.05 using Microsoft Excel 2010.

3. Results and discussion {#sec3}
=========================

3.1. Extraction and purification of the active compounds {#sec3.1}
--------------------------------------------------------

The 20 g dried leaf of *S. glauca* was yielded 3.6 g of ethanol crude extract, which had AGI activity. One gram of the crude extract was purified on a silica gel column and 16 fractions were collected. Each fraction was dried and analysed for the AGI activity. Out of 16 fractions, 'fraction-14' (20 mg) was found to be highly active against alpha glucosidase enzyme as represented in [Figure 1](#fig1){ref-type="fig"}. Further, the 'fraction-14' was analysed for phytochemicals and antioxidant assays along with the crude extract.Figure 1Silica gel column purified phenolic rich 'fraction-14'. Out of 16 fractions colleced from the silica gel column chromatography of ethanol extract from *S. glauca* leaf, the 'fraction-14' had high phenolic content and found to be highly active against alpha glucosidase enzyme.Figure 1

3.2. Phytochemical assays {#sec3.2}
-------------------------

### 3.2.1. Estimation of total phenolics and flavonoids {#sec3.2.1}

The total phenolic and flavonoid compounds of ethanol extract and purified 'fraction-14' are represented in [Table 1](#tbl1){ref-type="table"}. The total phenolic compounds in crude extract and purified 'fraction-14' were determined to be 414 ± 11 and 178 ± 7 mg GA/g of extract respectively. The total flavonoid content in crude ethanol extract was found to be 166 ± 29 mg Q/g of extract. However, flavonoid content was not detected in purified 'fraction-14' up to a concentration of 1 mg/mL. Earlier studies on *S. glauca*, Umesh et al. reported the phenolic contents of about 200 GA/g and flavonoids as 14.98 mg Q/g in the crude ethanol extract ([@bib55]). Another report confirmed the presence of phenolic compounds in ethanol extract as 84.55 ± 0.59 mg GA/g of extract ([@bib42]). Another group reported a very low level of phenolic and flavonoid compounds in the crude ethanol extract of *S. glauca* leaves as 0.12 ± 0.01 mg GA/g and 0.14 ± 0.02 mg Q/g of extract respectively ([@bib37]). However, all the earlier studies are on crude ethanol extract alone.Table 1Alpha-glucosidase inhibitory (AGI) activity, phytochemical analysis, antioxidant activity of ethanol crude extract and column purified 'fraction-14' of *S. glauca* leaf.Table 1SampleAGI activity (IC~50~ μg/mL)PhytochemicalsAntioxidant activity (IC~50~ in μg/mL)Total phenolics (mg GA/g)Total flavonoids (mg Q/g)DPPH AssayABTS AssayEthanol crude extract0.5 ± 0.04414 ± 11166 ± 2912.5 ± 0.64.0 ± 0.5Purified fraction-142.4 ± 0.40178 ± 70-14.4 ± 0.17.6 ± 0.5Ascorbic acid\-\--5.1 ± 0.13.9 ± 0.2Acarbose2450 ± 24\-\-\--[^1][^2]

Even though the phenolic compounds are ubiquitous in plants, their recovery greatly depends on their extraction method, solubility in the solvents, the extent of polymerization of phenols, the interference of other metabolites, the formation of insoluble complexes, etc ([@bib33]). In this study, the *S. glauca* leaf extract showed a high amount of total phenolic and flavonoid compounds than the previous reports. This observation is probably due to factors such as different geographical origin of the plant, environmental conditions, seasonal differences, solvents, etc ([@bib33]). Most of the earlier reports on plant extracts which had high phenolic compounds, also showed good antioxidant activity and AGI activity ([@bib8]; [@bib23]; [@bib46]; [@bib54]; [@bib61]). So, the present study was focused on the antioxidant property and identification of AGI from phenolic rich purified 'fraction-14' of *S. glauca*.

3.3. Antioxidant assays {#sec3.3}
-----------------------

DPPH and ABTS free radical scavenging activity of ethanol extract purified 'fraction-14' and a standard were determined and expressed their IC~50~ values as shown in [Table 1](#tbl1){ref-type="table"}. The DPPH free radical scavenging activity (IC~50~) of the ethanol extract and purified 'fraction-14' were 12.5 ± 0.6 and 14.4 ± 0.1 μg/mL respectively. Whereas, the ABTS free radical scavenging activity (IC~50~) for ethanol extract and purified 'fraction-14' were 4 ± 0.5 and 7.6 ± 0.5 μg/mL respectively. For both the assays, ascorbic acid was used as a positive control. DPPH and ABTS free radical scavenging ability of ascorbic acid were found to be 5.1 ± 0.1 and 3.9 ± 0.2 μg/mL respectively. Both the ethanol extract and purified 'fraction-14' had lower antioxidant activity than ascorbic acid.

The antioxidant properties of the phenolic and flavonoid compounds have been studied extensively for decades. It has been reported that the antioxidant properties of the phenolics and flavonoids are due to the presence of aromatic rings containing hydroxyl groups. These hydroxyl moieties associated with an aromatic ring can donate a hydrogen atom or an electron, chelate metals, activate antioxidant enzymes or inhibit oxidases ([@bib4]). Crude ethanol extract from *S. glauca* leaves containing phenolic and flavonoid were shown to possess good DPPH activity (IC~50~) of 13.12 μg/mL ([@bib55]) and 4.91 μg/mL ([@bib37]). The earlier report on ABTS free radical scavenging activity for the crude ethanol extract of *S. glauca* was 45.20 μg/mL ([@bib37]). In the present study, DPPH (IC~50~ = 12.5 ± 0.6 μg/mL) and ABTS (IC~50~ = 4 ± 0.5 μg/mL) values of crude ethanol extract (which had phenolics and flavanoids) are comparable to the antioxidant values of earlier studies. Similarly, another study on *S. glauca* leaves reported very low DPPH scavenging activity in ethyl acetate (IC~50~ = 1200 μg/mL) and petroleum ether (IC~50~ = 1280 μg/mL) extracts ([@bib45]). However, in the present study along with alpha glucosidase inhibition, the column purified 'fraction-14' of *S. glauca* also showed the presence of phenolics, as well as DPPH and ABTS free radical scavenging activity for the first time.

3.4. Yeast alpha glucosidase inhibition (AGI) assay {#sec3.4}
---------------------------------------------------

The AGI activities of ethanol extract and purified 'fraction-14' were represented in [Table1](#tbl1){ref-type="table"}. The ethanol extract exhibited good activity with an IC~50~ value of 0.5 ± 0.04 μg/mL. The AGI activity of 'fraction-14' showed the highest activity than the other fractions with an IC~50~ value of 2.4 ± 0.4 μg/mL as represented in [Table 1](#tbl1){ref-type="table"}. Also, [Table 2](#tbl2){ref-type="table"} represents the AGI activities of the remaining purified fractions of ethanol extract. Further, the crude ethanol extract and 'fraction-14' have shown very good inhibition of alpha glucosidase enzyme which are significantly better than the standard acarbose (IC~50~ = 2450 ± 24 μg/mL).Table 2Alpha-glucosidase inhibitory (AGI) activity of column purified fractions of ethanol extract from *S. glauca* leaf.Table 2S.N.Purified fractionsAGI activity (%Inhibition)11--12**-**21324.531478.741526.151639.1[^3]

There are several reports on the AGI activity of the phenolic extracts from other plants. The phenolic extract from *Panicum sumatrense* has shown AGI activity with an IC~50~ value of 18.97 ± 0.43 μg/mL against yeast enzyme ([@bib41]). The extractable and non-extractable polyphenols from *Camellia sinensis* exhibited yeast AGI activity with IC~50~ values of 0.77 ± 0.02 and 1.96 ± 0.21 μg/mL respectively ([@bib61]). The semi-purified phenolic rich extract of *Glycine max* L showed AGI activity against yeast enzyme with an IC~50~ value of 13.81 ± 0.081 μg/mL ([@bib54]). Also, the phenolic rich ethyl acetate extract of *Eucalyptus grandis* inhibited yeast AG enzyme with an IC~50~ value of 1.40 ± 0.18 μg/mL ([@bib23]). In another report, the phenolic extract of *Juglans regia* leaf showed AGI activity *in-vitro* and anti-hyperglycaemic effect against streptozotocin-induced rat models ([@bib35]).

However, there are few *in-vivo* studies on the anti-diabetic properties of the plant extracts from Simaroubaceae family. One study shows, the compounds bruceine E and D isolated from *Brucea javanica* lowers the blood glucose concentration by 73.57 ± 13.64% and 87.99 ± 2.91% respectively in streptozotocin-induced rat models, when compared to the non-treated streptozotocin-induced rats ([@bib36]). In another study, the methanolic extract of *Quassia amara at* 200 mg/kg dose reduces the elevated blood glucose level near to the normal in a streptozotocin-induced rat model ([@bib22]). But there are no available reports on *the in-vitro* or *in-vivo* analysis of *S. glauca* extracts for AGI activity. Hence, based on the available reports on the biological properties of different parts of *S. glauca*, the AGI activity is reported for the first time in this study.

It was interesting to observe that the *in-vitro* analysis of the purified 'fraction-14' showed about 1000-fold better AGI activity (IC~50~ = 2.4 ± 0.4 μg/mL) when compared to the standard acarbose (IC~50~ = 2450 ± 24 μg/mL), indicating the presence of highly potent inhibitor of AG in *S. galuca* leaf extract, which may be a potential lead molecule to treat T2DM.There was a marginal decrease in AGI activity of purified 'fraction-14' when compared to the crude extract, which could be due to the synergistic effect of phenolic compounds present in the crude extract ([@bib50]). The loss of activity in the purified fraction was also reported in earlier studies ([@bib54]; [@bib62]). Most of the reports on different plant extracts indicate the AGI activity of the phenolic extracts. The current study also showed the correlation between high phenolics of 'fraction-14' and its AGI activity. Hence, to identify the possible compounds responsible for AGI activity, the 'fraction-14' was characterized using UV-Visible, FTIR and LC-MS techniques.

3.5. Characterization {#sec3.5}
---------------------

### 3.5.1. UV-visible spectroscopy and FTIR analysis {#sec3.5.1}

The UV-visible spectroscopic analysis of the column purified 'fraction-14' showed two absorption peaks at 267 nm and 350 nm with the absorbance of 0.82 and 0.36 respectively indicating the presence of phenolic compounds as represented in [Figure 2](#fig2){ref-type="fig"}A. The above results correlate with the earlier studies, where they illustrate the presence of two absorption peaks for phenolic compounds in the range between 320 to 380 and 250--285 nm range in the UV region ([@bib32]).Figure 2UV-Visible spectroscopic analysis (A) and FTIR spectra (B) of column purified 'fraction-14' of ethanol extract from *S. glauca* leaf. For UV-Visible spectroscopy, the sample was dissolved in Milli-Q water at 0.25 mg/mL concentration. For FTIR, the sample was mixed with KBr at a ratio of 1:100, ground into a fine powder and a thin pellet was made.Figure 2

The FTIR analysis of purified 'fraction-14' shows several bands at different intensities as represented in [Figure 2](#fig2){ref-type="fig"}B. The band at 3433 cm^−1^ and 618 cm^−1^ may be due to stretching and bending vibration of -O-H groups respectively. The band at 2926 cm^−1^ could be attributed to the -C-H stretching of aromatics. The stretching vibration of --C=C- of aromatic rings could appear at 1611 cm^−1^. The band appeared at 1452 cm^−1^ could be attributed to the presence of aromatic --C=C- bond. The band appeared at 1700 cm^−1^ may be due to the stretching vibration of --C=O bond. These are the common bands present in the identified compound **1 (**eclalbasaponin V), **2 (**cyanidin-3-O-(2′galloyl)-galactoside), **3 (**kaempferol-3-O-glucoside) and **4 (**kaempferol-3-O-pentoside). However, two bands appeared at 1073 and 1205cm^−1^ which may be attributed to the symmetric and asymmetric vibrations of the O=S=O group of compounds **1**. The description of FTIR bands to the respective functional groups in this study are explained in comparison with the earlier reports ([@bib17]).

### 3.5.2. LC-MS analysis {#sec3.5.2}

The silica gel column purified 'fraction-14' was subjected to HPLC-Q--TOF-MS analysis to identify the possible compound responsible for the AGI activity. The LC-MS analysis of the compound showed two major peaks as represented in [Figure 3](#fig3){ref-type="fig"}. The LC-MS analysis of all the peaks of 'fraction-14' was represented in [Table 3](#tbl3){ref-type="table"}. The peaks at retention time between 16.4 - 18.8 min which had high intensity was annotated for m/z values. These m/z values were compared with the m/z values of the known phytochemical compounds, and four compounds were tentatively identified in negative ion mode. Figures [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, and [7](#fig7){ref-type="fig"} represents the Mass spectra of tentatively identified compounds. The structures of all four compounds are represented in [Figure 8](#fig8){ref-type="fig"}. The list of compounds with their m/z values along with the retention time and other data is represented in [Table 4](#tbl4){ref-type="table"}. The compound **1** with m/z 713.0965 \[M-H\]^¯^ is identified as eclalbasaponin V; a triterpenoid saponin has been identified previously in *Eclipta prostrata* L. The compound **2**; an anthocyanin, identified as cyanidin-3-O-(2′galloyl)-galactoside with m/z 599.1053 \[M-H\]¯ also reported previously from *Rhus coriaria* L ([@bib1]; [@bib20]) and *Victoria amazonica* ([@bib20]; [@bib52]). These compounds are rarely reported in green leaves. However, there are some reports on the presence of anthocyanins in early as well as later stages of the vegetative part including leaves and petioles ([@bib21]; [@bib28]). Study conducted by Manetas and group observed the presence of anthocyanins in the mature green leaves of *Rosa* sp. and *Ricinus communis* L ([@bib31]). Further, the presence of anthocyanins were documented in the leaves of tropical plants during their different stages of the development ([@bib29]). In the present study extract was from the leaves of different age groups along with petiole, might have contained anthocyanins. The compound **3** with m/z 447.0957 \[M-H\]¯ identified as kaempferol-3-O-glucoside has been reported previously in *Pollen Typhae, Phaseolus vulgaris L* and *Flaveria bidentis* (L.) Kuntze ([@bib9]; [@bib40]; [@bib60]). The compound **4** identified as kaempferol-3-O-pentoside showed molecular ion peak at m/z 417.0835 \[M-H\] ^¯^ has been identified previously in *Bauhinia* species and *Rubus grandifolius* Lowe. The compounds **3** and **4** belong to the flavonoid group ([@bib13]; [@bib18]). All the four compounds are reported in different plant species but, reported for the first time from *S. glauca.*Figure 3ESI-TIC spectra of column purified 'fraction-14'. The LC-MS peaks at retention time between 16.4-18.8 min which has high intensity was analysed for mass spectroscopy.Figure 3Table 3LC-MS analysis of purified 'fraction-14'. The peak at retention time between 16.4-18.8 min which had high intensity was annotated for m/z values.Table 3Show/HideCpdFileSaturatedRTPrecursorMassIon PolarityIonsHeightVolumeAlgorithmQuality ScoreTRUE27Fr.14.d-18.139447.0957448.1026Negative81195997445123Find by Molecular Feature100TRUE23Fr.14.d-16.956713.0965714.1038Negative4367901299330Find by Molecular Feature100TRUE26Fr.14.d-17.784599.1053600.1123Negative9364511476837Find by Molecular Feature100TRUE10Fr.14.d-9.625353.088354.0953Negative327554784165Find by Molecular Feature100TRUE30Fr.14.d-18.726417.0835418.0908Negative323452856989Find by Molecular Feature100TRUE22Fr.14.d-16.949577.0812578.0884Negative320970777064Find by Molecular Feature100TRUE2Fr.14.d-3.233362.9402363.9474Negative320155165424Find by Molecular Feature81.8TRUE1Fr.14.d-3.039362.9401363.9474Negative318606214072Find by Molecular Feature80TRUE18Fr.14.d-16.215729.0911730.0983Negative418606740919Find by Molecular100TRUE7Fr.14.d-5.027265.0929266.1Negative515749430217Find by Molecular Feature100TRUE11Fr.14.d-10.571183.03184.0373Negative214872541952Find by Molecular Feature100TRUE20Fr.14.d-16.94463.0883464.0952Negative713827571896Find by Molecular Feature91.3TRUE5Fr.14.d-3.889248.9602249.9675Negative213548449609Find by Molecular Feature100TRUE25Fr.14.d-17.778713.0958714.1031Negative311945395509Find by Molecular Feature100TRUE3Fr.14.d-3.345248.9601249.9674Negative211416106904Find by Molecular Feature100TRUE4Fr.14.d-3.854520.9083521.9156Negative210581175521Find by Molecular Feature100TRUE19Fr.14.d-16.221615.0978616.105Negative69636377572Find by Molecular Feature100TRUE6Fr.14.d-3.928154.9736155.9809Negative29430276406Find by Molecular Feature86.5TRUE16Fr.14.d-12.999633.0717634.079Negative59163226214Find by Molecular Feature100TRUE28Fr.14.d-18.165561.0843562.0916Negative38935408128Find by Molecular100TRUE9Fr.14.d-6.291169.0141170.0214Negative28767274588Find by Molecular100TRUE29Fr.14.d-18.718599.1034600.1103Negative68624495158Find by Molecular Feature82.1TRUE13Fr.14.d-11.465531.0956532.1029Negative38351248916Find by Molecular Feature100TRUE8Fr.14.d-5.294331.0664332.0737Negative37720221418Find by Molecular Feature100TRUE12Fr.14.d-11.455417.1032418.1104Negative57289230316Find by Molecular Feature87.1TRUE24Fr.14.d-17.763433.0768434.0841Negative46128231414Find by Molecular Feature100TRUE21Fr.14.d-16.949599.1024600.109Negative65973278252Find by Molecular Feature100TRUE17Fr.14.d-15651.1877652.195Negative35747180282Find by Molecular Feature80TRUE14Fr.14.d-12.015467.0797468.0869Negative35336198210Find by Molecular Feature100TRUE15Fr.14.d-12.023353.0873354.0946Negative25135154844Find by Molecular Feature100Figure 4Mass spectra of eclalbasaponin V (compound 1). The m/z value was obtained in negative ionization mode and compared with m/z value of previously identified compounds in literature.Figure 4Figure 5Mass spectra of cyanidin-3-O- (2′galloyl)-galactoside (compound 2). The m/z value was obtained in negative ionization mode and compared with m/z value of previously identified compounds in literature.Figure 5Figure 6Mass spectra of kaempferol-3-O-glucoside (compound 3). The m/z value was obtained in negative ionization mode and compared with m/z value of previously identified compounds in literature.Figure 6Figure 7Mass spectra of kaempferol-3-O-pentoside (compound 4). The m/z value was obtained in negative ionization mode and compared with m/z value of previously identified compounds in literature.Figure 7Figure 8Chemical structures of tentatively identified compounds from column purified 'fraction-14' of ethanol extract from *S. glauca* leaf using LC-MS analysis. The compounds were identified based on the comparison of m/z values with m/z values of previously identified compounds in literature.Figure 8Table 4Identified compounds from column purified 'fraction-14' using HPLC-Q--TOF-MS analysis.Table 4S.N.R~t~ (min)Observed m/z \[M-H\] ¯Other fragmentsm/z \[M-H\] ¯ from literatureTentative identification0116.956713.0965-713.3582Eclalbasaponin V0217.784599.1053635.0789 \[M + Cl\] ¯, 1199.2130\[2M-H\] ¯599.1039Cyanidin-3-O- (2′galloyl)-galactoside0318.139447.0957895.1928 \[2M-H\] ¯447.0957Kaempferol-3-O-glucoside0418.726417.0835-417.0845Kaempferol-3-O-pentoside[^4]

Although these four compounds are reported by others, there is no available literature on the biological activities of these compounds. However, biological activity was analysed for the compounds eclalbasaponin, eclalbasaponin I and eclalbasaponin II which are closely related to the compound **1** ([@bib11]; [@bib43]; [@bib59]). Many anthocyanins, other than compound **2,** showed antioxidant activity and anti-inflammatory activities in an earlier report ([@bib5]; [@bib27]). Compound **3** was previously identified in *Helichrysum compactum* extract, which showed antioxidant activity ([@bib53]). In another study, the semi-purified fraction of legumes showed AGI activity and later on one of the compounds from this fraction was identified as kaempferol-3-O-glucoside ([@bib54]). However, antioxidant activity, AGI activity, and antiproliferation effect have been determined in the crude extracts of *Bauhinia* species and *Euphorbia supina*, where later characterization of the extracts confirms the presence of compound **4** which is also identified in the present study as kaempferol-3-O-pentoside ([@bib13]; [@bib51]).

Recently, many purified compounds like rhinacanthin C (IC~50~ = 22.6 ± 0.6 μg/mL) ([@bib48]), norathyriol (IC~50~ = 4.22 ± 0.19 μg/mL) ([@bib19]), mangiferin (IC~50~ = 36.84 μg/mL) ([@bib47]), etc. have been reported as AGI from different medicinal plants. The purified 'fraction-14' in this study showed better AGI activity (IC~50~ = 2.4 ± 0.4 μg/mL) than the above-mentioned compounds. Compounds **3** and **4** identified in this study may contribute to the AGI activity and antioxidant activity observed in 'fraction-14', as these compounds are already known for alpha glucosidase inhibition and antioxidant properties according to the earlier reports ([@bib13]; [@bib51]; [@bib54]). So, the purified 'fraction-14' is expected to have a higher potential inhibitor for an alpha glucosidase enzyme and can be used for T2DM treatment after a detailed toxicological, *in-vivo* and clinical studies.

3.6. Enzyme inhibitory kinetics {#sec3.6}
-------------------------------

The double reciprocal Lineweaver-Burk plot was used to determine the mode of inhibition and kinetic parameters for the column purified 'fraction-14'. [Figure 9](#fig9){ref-type="fig"}A represents the Lineweaver-Burk plot for different concentrations of inhibitor (purified 'fraction-14') analysed for different concentrations of the substrate (PNPG). In this plot all lines drawn were intersected at the second quadrant, which indicates, the purified 'fraction-14' exhibited the mixed type of inhibition on the alpha glucosidase enzyme. Also, the apparent *V*~*max*~ was slightly changed and Michaelis-Menten constant, *K*~*m*~ values were increasing with the increasing concentration of inhibitor as shown in [Table 5](#tbl5){ref-type="table"}. This behaviour indicate that the inhibitor prefers binding to the free enzyme rather than the enzyme-substrate complex. Precisely, [Figure 9](#fig9){ref-type="fig"}B represents the slope versus inhibitor was a linear fit, which shows, the purified 'fraction-14' has a single inhibition site or a single class of inhibition on the alpha glucosidase enzyme. Our findings are in line with previous reports where kaempferol and hesperetin show the mixed type inhibition on yeast alpha glucosidase enzyme. Interestingly, unlike acarbose (a competitive inhibitor), where its effectiveness is found to be hindered by the high concentration of carbohydrate intake, the mixed inhibitors would still be effective at lower concentration ([@bib16]; [@bib38]; [@bib44]). Furthermore, the inhibition constant, *K*~*i*~ for purified 'fraction-14' is 6.2 μg/mL which is better than the acarbose (*K*~*i*~ = 49 mg/mL) reported in the earlier study ([@bib26]).Figure 9Lineweaver- Burk plots (A) and Secondary plot of slope versus inhibitor ('fraction-14') (B). The inhibitor concentrations were used as 0.83, 1.66, 3.32 and 4.15 μg/mL. Alpha glucosidase concentration was 0.02 units/mL. Substrate, PNPG concentrations were 0.01, 0.02, 0.04, 0.08, 0.1, 0.2, 0.4 and 0.8 mM.Figure 9Table 5Maximum velocity; *V*~*max*~ and Michaelis-Menten constant; *K*~*m*~ for different concentrations of column purified 'fraction-14'.Table 5S.N.Fraction-14 (μg/mL)*V*~*max*~ (μM/min.)*K*~*m*~ (μM)102.957020.832.507431.662.338043.322.289054.152.1390[^5]

3.7. Homology model {#sec3.7}
-------------------

The homology model of *S. cerevisiae* alpha glucosidase was generated using *S. cerevisiae* isomaltase (PDB:[3A47](pdb:3A47){#intref0030}; 71.8% sequence identity and 84.9% similarity with *S. cerevisiae* alpha glucosidase) and MalL mutant enzyme from *Bacillus subtilis* (PDB:[4MB1](pdb:4MB1){#intref0035}; 41% sequence identity and 58.8% similarity with *S. cerevisiae* alpha glucosidase) as templates. [Figure 10](#fig10){ref-type="fig"} represents the structure of *S. cerevisiae* alpha glucosidase in a surface view generated using RaptorX software. The active site of the enzyme is represented in the yellow-coloured patch where all the identified compounds are perfectly stacked during the docking study. [Figure 11](#fig11){ref-type="fig"} represents the Ramachandran plot where 90.5% residues reside in the most favoured region, 8.5% residues reside in additional allowed regions, 0.8% residues located in generously allowed regions and 0.2% residues located in disallowed regions. Analysis of the Ramachandran plot further strengthens the quality of *the S. cerevisiae* alpha glucosidase homology model. So, the validated and analysed homology model was used for the docking study.Figure 10Surface representation of modelled structure of the yeast alpha glucosidase. The structure was generated using RaptorX software. The active site of the enzyme is represented in a yellow-colored patch where the docked compounds interacts with enzyme which involves both hydrogen bonds and hydrophobic interactions.Figure 10Figure 11Ramachandran plot for homology model of yeast alpha glucosidase. The homology model was built using RaptorX software. The model was validated and authenticated by Ramachandran plot using PROCHECK software.Figure 11

3.8. Docking study {#sec3.8}
------------------

A docking study was performed to predict the mode of interaction between the identified compounds and the alpha glucosidase enzyme. The homology modelling of *S. cerevisiae* alpha glucosidase and docking studies have been reported in earlier studies where several compounds were docked with the alpha glucosidase enzyme ([@bib15]; [@bib39]; [@bib58]). The docking study of the identified compounds are represented in [Figure 12](#fig12){ref-type="fig"} and [Figure 13](#fig13){ref-type="fig"}. The binding energy of the compounds and active site residues of *S. cerevisiae* alpha glucosidase are represented in [Table 6](#tbl6){ref-type="table"}. Among the docked compounds, compound **2** showed highest binding energy as -7.769 kJ/mol followed by compound **3**, compound **4**, acarbose and compound **1** at binding energy -7.127, -7.04, -6.867 and -4.409 kJ/mol respectively. The compound **1** showed only one hydrogen bond interaction with the main-chain of residue PHE157 as shown in [Figure 12](#fig12){ref-type="fig"}A and stabilized in the active site pocket with hydrophobic interactions with residues PHE310, 231, 300, 311, 158, 177, TRP242 and TYR313 as represented in [Figure 12](#fig12){ref-type="fig"}B and [Table 6](#tbl6){ref-type="table"}. [Figure 12](#fig12){ref-type="fig"}C represents the mode of interaction between compound **2** and enzyme in a stick view. The cyanidin moiety of compound **2** showed five hydrogen bond interactions with the residues HIS245, ASP408, 349, PHE157 and ARG439. The galactoside moiety showed hydrogen bond interaction with PRO309 while GLU304 involved in the hydrogen bonding interaction with the galloyl moiety of compound **2.** Further, surface characteristic of compound **2** is perfectly complementary to the active site and stacks deep inside the active site pocket of the enzyme with several hydrophobic interactions such as PHE177, 310, 231, 311, 158, 300 and TYR313 as represented in [Figure 12](#fig12){ref-type="fig"}D and [Table 6](#tbl6){ref-type="table"}.Figure 12Docking study of compounds 1 and 2 with yeast alpha glucosidase. Interaction of compound 1 in stick representation (A) and surface representation form (B); and interaction of compound 2 in stick representation (C) and surface representation form (D) with active site residues of alpha glucosidase. The compounds were perfectly stacked inside the active site pocket of the enzyme with several hydrogen bonds and hydrophobic interactions. The hydrogen bond interactions were represented in black coloured broken lines.Figure 12Figure 13Docking study of compounds 3 and 4 with yeast alpha glucosidase. Interaction of compound 3 in stick representation (A) and surface representation form (B); and interaction of compound 4 in stick representation (C) and surface representation form (D) with active site residues of alpha glucosidase. The compounds were perfectly stacked inside the active site pocket of the enzyme with several hydrogen bonds and hydrophobic interactions. The hydrogen bond interactions were represented in black coloured broken lines.Figure 13Table 6Binding energy of the compounds and interacting active site residues of *Saccharomyces cerevisiae* alpha-glucosidase.Table 6S.N.CompoundBinding energy (KJ/mol)Interacting residues of the active site1Eclalbasaponin V-4.409PHE157, 310, 231, 300, 311, 158, 177, TRP242, TYR3132Cyanidin-3-O- (2′galloyl)-galactoside-7.769HIS245, PRO309, ASP408, 349, GLU304, ARG439, PHE157, 177, 310, 231, 311, 158, 300, TYR3133Kaempferol-3-O-glucoside-7.127PRO309, ARG312, THR215, ASP349, 408, TYR313, GLN350, PHE157, 158, 300, 177, 3114Kaempferol-3-O-pentoside-7.04THR215, ASP349, 408, GLN350, TYR313, ARG312, PRO309, PHE300, 157, 177, 158, 3115Acarbose-6.867PRO309, HIS239,279, ASP349, SER156, ARG439, THR215, GLU276, ASP214, PHE310, 300, 157, 177, 311, 158, TYR17, 313[^6]

Similarly, the kaempferol moieties of the compounds **3** and **4** make hydrogen bond interactions with the residues THR215, PRO309, ARG312. The glucoside and pentoside moieties of both the compound are involved in hydrogenbond interaction with ARG312, ASP349, 408, TYR313 and GLN350 as represented in [Figure 13](#fig13){ref-type="fig"}A and [Figure 13](#fig13){ref-type="fig"}C. Further, both the compounds were stabilized in the active site pocket due to hydrophobic interactions with residues PHE157, 158, 300, 177, 311 as represented in [Figure 13](#fig13){ref-type="fig"}B, [Figure13](#fig13){ref-type="fig"}D and [Table 6](#tbl6){ref-type="table"}. [Figure 14](#fig14){ref-type="fig"} represents the superimposition of the docked compounds in the active site pocket of the enzyme. Kaempferol, glucoside moieties of the compounds **3** and pentoside moiety of compound **4** were perfectly superimposed to each other, which indicates the similar kind of interactions of both the compounds with the enzyme. Also, the docking study was performed with antidiabetic drug acarbose represented in [Figure 15](#fig15){ref-type="fig"} and [Table 6](#tbl6){ref-type="table"}. The acarvosine ring showed hydrogen bond interactions with residues PHE310, PRO309, HIS239 and SER156. The maltose unit occupied the active site pocket with hydrogen bond interaction with residues ARG439, GLU276, THR215, ASP349, HIS279 and ASP214 as represented in [Figure 15](#fig15){ref-type="fig"}A. Further, the acarbose was stabilized in the active site pocket with residues PHE310, 300, 157, 177, 311, 158, TYR71 and 313 as represented in [Figure 15](#fig15){ref-type="fig"}B and [Table 6](#tbl6){ref-type="table"}.Figure 14Superimposition of the docked compounds in the active site of the enzyme. Compounds 1, 2, 3 and 4 were represented in yellow, orange, blue and purple coloured sticks respectively.Figure 14Figure 15Docking study of acarbose with yeast alpha glucosidase. (A) Stick representation and (B) Surface representation. The hydrogen bond interactions were represented in black coloured broken lines.Figure 15

In this study docking of the identified compounds reported for the first time. Similar to the *in-vitro* AGI activities, identified compounds from the 'fraction-14' have shown better binding activities when compared to the standard drug acarbose. Though, there are no literature available on docking studies of these compounds, the binding energy of compounds **2, 3** and **4** with the yeast alpha glucosdiase are very promising. If the identified compounds preserve an effective binding affinity against human alpha glucosidase enzyme similar to this study, there would be an opportunity to develop these molecules into a new alpha glucosidase inhibitor.

Quassinoids and other compounds like kaempferol, amarolide, saponin, etc. have been isolated and reported in Simaroubaceae family for different biological activities including antidiabetic activity ([@bib3]). But, the detailed study on antidiabetic properties of isolated compounds from Simaroubaceae family are lacking except for few studies on *Quassia amara* ([@bib22]) and *Brucea javanica* plants ([@bib36]). In the present study, alpha glucosidase inhibition activity of the purified 'fraction-14' was analysed using *in-vitro*, *in-silico* as well as kinetic study indicates that there are effective inhibitors present in the *S. glauca* leaf extract. This study would be a inspiration for further detailed studies on these identified compounds to develop them as a novel natural alpha glucosidase inhibitor.

4. Conclusion {#sec4}
=============

To the best of our knowledge, the detailed study on phytochemical analysis, antioxidant activity, AGI activity, kinetics and docking studies of purified phenolic rich fraction from *S. glauca* leaf was conducted for the first time in this report. The column purified 'fraction-14' of *S. glauca* possess high AGI activity when compared to commercial drug acarbose. The antioxidant activity and high alpha glucosidase inhibition activity of 'fraction-14' is comparable to the earlier studies and, the presence of phenolics was confirmed by phytochemical study. The strong AGI activity was proved by the inhibition kinetic study which shows the mixed type of inhibition on the alpha glucosidase enzyme. The superior *K*~*i*~ value than the acarbose suggests that the compounds present in the 'fraction -14' would have an effective AGI for the management of T2DM. The LC-MS analysis of purified 'fraction-14' lead to the identification of four compounds (compounds **1**, **2**, **3** and **4**), out of them, two compounds are already known for AGI activity and antioxidant activity. The docking study also showed that compounds **2**, **3** and **4** have higher binding energy than the known drug acarbose against alpha glucosidase, which indicates the identified compounds are better AGI than the acarbose. The phenolic rich and antioxidant fraction with significant AGI activity is a promising result for its application as a therapeutic agent to treat T2DM. Even though the *in-vitro* analysis exhibits excellent AGI activity, the implication of *in-vivo* studies would reveal the potentiality of these molecules before considering for the T2DM treatment.
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[^1]: Note: AGI activity and antioxidant activity are represented by IC~50~ values. Acarbose was used as a standard for AGI activity. Total phenolics are represented in mg GA per gram of extract. Total flavonoids are represented in mg Q per gram of extract. Ascorbic acid was used as standard for antioxidant activities. All the experiments are expressed as mean ± SD (n = 3). The values are statistically significant at p \< 0.05.

[^2]: Q: Quercetin, GA: Gallic acid, SD: Standard Deviation, "-": Not determined.

[^3]: Note: AGI values are represented in percentage inhibition at the sample concentration of 0.05 mg/mL "-": Not observed.

[^4]: Note: The m/z values were obtained in negative ionization mode. Compounds **(S.N. 1,2, 3 & 4)**were identified based on comparison of m/z values with the previous reports. "-": Not observed.

[^5]: Note: The alpha glucosidase concentration was 0.02 units/mL. The substrate, PNPG concentration was 0.01, 0.02, 0.04, 0.08, 0.1, 0.2, 0.4 and 0.8 mM. The differences among the values are considered to be statistically significant at p \< 0.05. PNPG: p-nitrophenyl-α-D-glucopyranoside.

[^6]: Note: The hydrogen bond interactions and hydrophobic interctions were observed during the docking study.
